loading page

Microvascular Angiopathic Consequences of COVID-19
  • +1
  • Margaret Nalugo,
  • Linda Schulte,
  • Muhammad Faraz Masood,
  • Mohamed Zayed
Margaret Nalugo
Washington University in St Louis School of Medicine
Author Profile
Linda Schulte
Washington University in St Louis School of Medicine
Author Profile
Muhammad Faraz Masood
Washington University in Saint Louis School of Medicine
Author Profile
Mohamed Zayed
Washington University in St Louis School of Medicine
Author Profile

Abstract

The coronavirus disease-2019 (COVID-19) pandemic has rapidly spread across the world. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan, China in December, 2019. Ever increasing data is emerging about COVID-19 and its effects on the arterial and venous circulation. Clinical features associated with COVID-19 suggest that endothelial cell dysfunction and microvascular thrombosis are to a large part contributing to resultant multi-organ complications. This review is aimed at highlighting the critical aspects associated with COVID-19 and its presumed microvascular angiopathic complications leading to multi-organ dysfunction.